Skip to content
Clinical Trials – home

Centrum Medyczne LukaMed Joanna Łuka

Verifiedinfo

Poland Ul. Mickiewicza 39, 89-600 Chojnice, Poland

  • 3 trials recruiting
  • Colitis ulcerative · Crohn's disease · Arteriosclerosis
  • Adults and children

About Specializations

Centrum Medyczne LukaMed Joanna Łuka in Chojnice, Poland specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, Arteriosclerosis, Psoriasis, and other specialisations. This site conducts important research.

Main research areas of the site

Gastroenterology

The medical center is at the forefront of gastroenterology, focusing on innovative treatments for complex digestive disorders. The ongoing research aims to enhance the understanding and management of conditions such as idiopathic and diabetic gastroparesis.

  • Idiopathic Gastroparesis
  • Diabetic Gastroparesis
  • Delayed Gastric Emptying

Through rigorous clinical trials, the center is dedicated to discovering optimal therapeutic strategies, improving patient outcomes, and advancing the field of digestive health.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Mickiewicza 3989-600 ChojnicePoland
Recruiting now
3 trials
Conditions studied
9
Partner status
Verified

More sites in ChojnicePoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

17 clinical trials

Crohn's disease

Recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sar442970
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ro7790121
  • Sponsor:F. Hoffmann-La Roche AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:TAZAROTENE
  • Sponsor:Bausch Health Americas Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Alvotech Swiss AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Vedolizumab
  • Sponsor:Polpharma Biologics S.A.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Crohn's disease

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Naronapride Dihydrochloride Trihydrate
  • Sponsor:Dr. Falk Pharma GmbH

Colitis ulcerative

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rifamycin Sodium
  • Sponsor:Cosmo Technologies Limited
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.